Relic Technologies Limited Reports No Deviation in Fund Utilization for Q3 FY26

Relic Technologies Limited has filed its quarterly compliance report with BSE Limited, confirming that there has been no deviation or variation in the utilization of proceeds from its preferential issue for the quarter ended December 31, 2025. The statement was submitted on February 12, 2026, in accordance with Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Fund Raising Details The company raised funds through a preferential issue in two phases during 2025. The fund raising activities were structured as follows: Component Date Amount Equity Shares Allotment April 5, 2025 Rs. 1,317.50 lakhs Fully Convertible Warrants (25%) April 5, 2025 Rs. 93.74 lakhs Warrant Conversion (75%) December 13, 2025 Rs. 281.24 lakhs Total Amount Raised Rs. 1,692.48 lakhs The equity shares carry a face value of Rs. 10 each, and the fully convertible warrants had a total value of Rs. 374.98 lakhs, with 25% paid upfront and the remaining 75% paid upon conversion to equity shares. Fund Utilization Status The company's fund utilization for the quarter ended December 31, 2025, demonstrates adherence to the original objectives outlined in the preferential issue: Parameter Details Quarter Utilization Rs. 95 lakhs Cumulative Utilization Rs. 478 lakhs Total Funds Available Rs. 1,692.48 lakhs Deviation Status No Deviation The proceeds are being utilized for meeting working capital requirements, investment and acquisition of entities, further investment in or granting of loans to other entities, and for general corporate purposes, exactly as proposed in the original fund-raising document. Regulatory Compliance The utilization statement was duly reviewed by the company's Audit Committee at its meeting held on February 12, 2026. The Audit Committee confirmed that "the utilization of the proceeds from the preferential issue has been noted and is in line with the objects of the issue." The funds were originally approved through resolutions passed at the Extra-Ordinary General Meeting held on March 18, 2025. The company has maintained full compliance with the stated objectives without any modification to the original allocation or purposes. Corporate Information Relic Technologies Limited operates under CIN L46497MH1991PLC064323 and is headquartered in Mumbai. The compliance statement was signed by Karthik Swaminathan Iyer, Executive Director (DIN: 08216928), confirming the company's adherence to regulatory requirements and transparent fund utilization practices. Relic Technologies Limited has released its unaudited financial results for the quarter and nine months ended December 31, 2025, revealing a stark contrast between its standalone and consolidated performance. The Mumbai-based company, which is transitioning its business activities to pharma and wellness products, demonstrated mixed operational outcomes during the reporting period. Standalone Financial Performance The company's standalone operations showed positive results for Q3FY26, despite the absence of operational revenue. Key financial metrics for the quarter demonstrate the company's reliance on non-operational income sources. Metric Q3FY26 Q3FY25 Change Revenue from Operations - ₹46.92 lakhs - Other Income ₹35.04 lakhs ₹2.91 lakhs +1104.47% Total Income ₹35.04 lakhs ₹49.83 lakhs -29.67% Net Profit/(Loss) ₹17.38 lakhs ₹(151.23) lakhs Positive turnaround Basic EPS ₹0.34 ₹(4.20) Positive turnaround For the nine-month period ended December 31, 2025, standalone operations generated a net profit of ₹44.71 lakhs compared to a loss of ₹147.49 lakhs in the corresponding period of the previous year. The company maintained zero revenue from operations throughout the nine-month period, with total income of ₹92.76 lakhs coming entirely from other income sources. Consolidated Results Show Operational Challenges The consolidated financial results, which include subsidiaries Relic Pharma Ltd and Truhealthy Wellness Private Ltd, presented a different picture with operational revenue but significant losses. Metric Q3FY26 Q3FY25 Change Revenue from Operations ₹32.16 lakhs ₹46.92 lakhs -31.43% Total Income ₹49.88 lakhs ₹49.83 lakhs +0.10% Total Expenses ₹206.04 lakhs ₹149.65 lakhs +37.70% Net Loss ₹(47.67) lakhs ₹(99.82) lakhs Reduced loss Basic EPS ₹(0.92) ₹(2.77) Improved The consolidated nine-month results showed a substantial net loss of ₹400.79 lakhs compared to ₹96.08 lakhs in the previous year. This significant increase in losses was attributed to higher operational expenses, particularly employee benefit expenses which rose to ₹333.38 lakhs from ₹22.73 lakhs in the corresponding period. Capital Structure Enhancement During Q3FY26, Relic Technologies strengthened its capital base through warrant conversions. The company successfully converted 4,41,164 warrants into equity shares following receipt of the balance 75% application money from warrant holders. Parameter Details Warrants Converted 4,41,164 Face Value per Share ₹10 Updated Paid-up Capital ₹559.12 lakhs Total Equity Shares 55,91,640 This capital expansion increased the company's paid-up equity capital from ₹515.00 lakhs in the previous quarter to ₹559.12 lakhs as of December 31, 2025. Business Transition Update The company provided an important update regarding its strategic shift toward pharma and wellness products. Management disclosed that the planned change of activities to dealing in pharma and wellness products had not yet commenced revenue generation by December 31, 2025, as the company was still in the process of obtaining necessary regulatory permissions. Subsidiary Performance Impact The consolidated results were significantly influenced by subsidiary operations, with the two subsidiaries contributing ₹32.30 lakhs in revenue for the quarter and ₹220.48 lakhs for the nine-month period. However, these subsidiaries also reported substantial losses, with net loss before tax of ₹172.77 lakhs for the quarter and ₹414.32 lakhs for the nine-month period, highlighting operational challenges in the subsidiary businesses. The financial results were approved by the Board of Directors in their meeting held on February 12, 2026, and have received unmodified review opinions from the company's statutory auditors, D. Kothary & Co., Chartered Accountants. We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better. Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians. As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.